{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Immunodificency panel to see recovery of immune system. Number of participants that recovered.","groups":[{"description":"PREPARATIVE REGIMEN: Patients receive oral busulfan on days -8 to -5, cyclophosphamide IV on days -4 to -3, and anti-thymocyte globulin or methylprednisolone IV on days -3 to -1. TRANSPLANTATION: Patients undergo a double-unit umbilical cord blood allogeneic stem cell transplantation on day 0. GRAFT-VS-HOST DISEASE PROPHYLAXIS: Beginning on day -2, patients receive cyclosporine IV and taper beginning on day 100. Patients also receive mycophenolate mofetil IV or orally on days -3 to 45.","id":"OG000","title":"Arm I"}],"populationDescription":"Data not collected, panel not done because of funding.","reportingStatus":"POSTED","timeFrame":"Periodically for 2 years","title":"Immune Reconstitution","type":"SECONDARY"}